New blood test could make hemophilia treatment safer
NCT ID NCT07101926
First seen Nov 01, 2025 · Last updated May 22, 2026 · Updated 28 times
Summary
This study aims to create a reliable lab test to monitor anti-TFPI antibodies, a new type of treatment for hemophilia. Researchers will test blood samples from 11 men with severe hemophilia who are already taking the anti-TFPI drug Marstacimab. The goal is to better measure how well the treatment works, especially during surgery or severe bleeding, to improve patient safety.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEMOPHILIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Centre de Référence Hémophilie et autres déficits rares en protéine de la coagulationCentre de Traitemendes Hémophiles F. Josso
NOT_YET_RECRUITINGParis, 75015, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Groupement hospitalier Est Hôpital Cardilogique Service d'hémostase clinique
RECRUITINGBron, 69677, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.